Cocrystal Pharma, Inc. · NASDAQ:COCP
Phillip Frost, M.D. reported a 13.90% stake in Cocrystal Pharma, Inc. (Schedule 13D/A)
Event Aug 3, 2026 · Filed Aug 7, 2026
Phillip Frost, M.D. reported a 13.90% stake in Cocrystal Pharma, Inc., 2,784,719 shares, with active intent on Aug 3, 2026. Filed Aug 7, 2026 (Schedule 13D/A).
- Stake
- 13.90%
- Shares
- 2,784,719
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Phillip Frost, M.D. | 13.90% | 2,784,719 |
| Frost Gamma Investments Trust | 13.50% | 2,712,977 |
Source
Related
- Cocrystal Pharma, Inc.
- Frost Gamma Investments Trust
- Cocrystal Pharma, Inc. shareholders
- Schedule 13D/A · Frost Gamma Investments Trust · Oct 30, 2025
- Schedule 13D/A · Frost Gamma Investments Trust · Oct 2, 2025
- Schedule 13D · Opko Health, Inc. · Aug 7, 2026
- Form 4 · Frost Gamma Investments Trust · Aug 6, 2026
- Form 4 · Frost Gamma Investments Trust · Aug 5, 2026